Financials Mitsui Chemicals, Inc.

Equities

4183

JP3888300005

Commodity Chemicals

Market Closed - Japan Exchange Other stock markets 01:30:00 2025-01-21 am EST			5-day change	1st Jan Change
3,316.00 ^JPY	+0.36%		+1.13%	-4.44%

Dec. 29	Mitsui Chemicals Spends 2.16 Billion Yen in Share Repurchase	MT
Dec. 24	Tranche Update on Mitsui Chemicals, Inc.'s Equity Buyback Plan announced on November 22, 2024.	CI

Projected Income Statement: Mitsui Chemicals, Inc.

income-statement-evolution-chart MITSUI-CHEMICALS-INC

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	1,338,987	1,211,725	1,612,688	1,879,547	1,749,743	1,821,383	1,866,524	1,904,455
Change	-	-9.5%	33.09%	16.55%	-6.91%	4.09%	2.48%	2.03%
EBITDA ¹	123,742	153,242	231,532	221,078	169,373	204,176	235,568	256,060
Change	-	23.84%	51.09%	-4.52%	-23.39%	20.55%	15.38%	8.7%
EBIT ¹	71,636	85,140	147,310	128,998	74,124	101,778	126,776	143,695
Change	-	18.85%	73.02%	-12.43%	-42.54%	37.31%	24.56%	13.35%
Interest Paid ¹	-5,501	-8,128	-12,211	-17,398	-14,663	-8,000	-8,000	-8,000
Earnings before Tax (EBT) ¹	68,460	74,243	141,274	117,278	73,331	95,098	120,486	139,128
Change	-	8.45%	90.29%	-16.99%	-37.47%	29.68%	26.7%	15.47%
Net income ¹	37,944	57,873	109,990	82,936	49,999	63,324	81,292	94,188
Change	-	52.52%	90.05%	-24.6%	-39.71%	26.65%	28.37%	15.86%
Announcement Date	5/14/20	5/13/21	5/13/22	5/12/23	5/15/24	-	-	-

¹JPY in Million

Estimates

Fiscal Period: March	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2
Net sales ¹	324,138	339,935	254,500	282,479	320,449	354,297	370,591	372,944	421,544	447,609	476,113	474,964	477,834	450,636	407,925	415,730	450,875	475,213	449,471	440,880	457,830	472,930	440,000	458,200	466,400	482,300	448,300	468,400
Change	-	4.87%	-25.13%	10.99%	13.44%	10.56%	4.6%	0.63%	13.03%	6.18%	6.37%	-0.24%	0.6%	-5.69%	-9.48%	1.91%	8.45%	5.4%	-5.42%	-1.91%	3.84%	3.3%	-6.96%	4.14%	1.79%	3.41%	-7.05%	4.48%
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBIT ¹	18,535	18,630	-48	17,949	34,026	32,960	53,227	41,272	41,527	11,284	42,949	29,559	34,510	21,980	13,887	17,358	28,778	14,101	27,202	18,790	25,702	25,282	33,800	36,500	31,000	23,600	36,900	39,900
Change	-	0.51%	-	-	89.57%	-3.13%	61.49%	-22.46%	0.62%	-72.83%	280.62%	-31.18%	16.75%	-36.31%	-36.82%	24.99%	65.79%	-51%	92.91%	-30.92%	36.78%	-1.63%	33.69%	7.99%	-15.07%	-23.87%	56.36%	8.13%
Charge d'intérêts	-1,344	-1,306	-2,133	-	-3,213	-	-2,092	-	-5,075	-	-6,455	-	-705	-	-4,196	-	-892	-	-4,125	-	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	22,592	22,613	-546	16,292	30,939	27,558	51,885	40,471	37,223	11,695	40,819	29,835	29,533	17,091	14,151	18,827	26,196	14,157	29,273	11,563	29,066	24,467	-	-	-	-	40,880	34,820
Change	-	0.09%	-	-	89.9%	-10.93%	88.28%	-22%	-8.03%	-68.58%	249.03%	-26.91%	-1.01%	-42.13%	-17.2%	33.04%	39.14%	-45.96%	106.77%	-60.5%	151.37%	-15.82%	-100%	-	-	-	-	-14.82%
Net income ¹	15,366	10,820	-2,300	11,920	23,399	24,872	42,624	31,316	26,127	9,923	27,992	16,361	20,593	17,990	9,591	11,096	16,574	12,738	17,889	4,340	21,957	16,500	-	-	-	-	27,700	23,600
Change	-	-29.58%	-	-	96.3%	6.3%	71.37%	-26.53%	-16.57%	-62.02%	182.09%	-41.55%	25.87%	-12.64%	-46.69%	15.69%	49.37%	-23.14%	40.44%	-75.74%	405.92%	-24.85%	-100%	-	-	-	-	-14.8%
Announcement Date	2/5/20	5/14/20	8/13/20	11/11/20	2/9/21	5/13/21	8/5/21	11/5/21	2/3/22	5/13/22	8/5/22	11/8/22	2/3/23	5/12/23	8/4/23	11/8/23	2/7/24	5/15/24	8/6/24	11/7/24	-	-	-	-	-	-	-	-

¹JPY in Million

Estimates

Fiscal Period: March	2021 S1	2021 S2	2022 S1	2022 S2	2023 S1	2023 S2	2024 S1	2024 S2	2025 S1	2025 S2
Net sales ¹	536,979	674,746	743,535	869,153	951,077	928,470	823,655	926,088	890,351	882,300
Change	-	25.66%	10.19%	16.89%	9.43%	-2.38%	-11.29%	12.44%	-3.86%	-0.9%
EBITDA	-	-	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-	-
EBIT	17,901	66,566	94,499	52,811	72,508	56,490	31,245	42,879	45,992	-
Change	-	271.86%	41.96%	-44.11%	37.3%	-22.09%	-44.69%	37.23%	7.26%	-100%
Charge d'intérêts	-5,538	-	-4,227	-	-9,297	-	-7,057	-	-9,035	-
Earnings before Tax (EBT)	15,746	58,497	92,356	48,918	70,654	46,624	32,978	40,353	40,836	-
Change	-	271.5%	57.88%	-47.03%	44.43%	-34.01%	-29.27%	22.36%	1.2%	-100%
Net income	9,602	48,271	73,940	36,050	44,353	38,583	20,687	29,312	22,229	-
Change	-	402.72%	53.18%	-51.24%	23.03%	-13.01%	-46.38%	41.69%	-24.16%	-100%
Announcement Date	11/11/20	5/13/21	11/5/21	5/13/22	11/8/22	5/12/23	11/8/23	5/15/24	11/7/24	-

¹JPY in Million

Estimates

Forecast Balance Sheet: Mitsui Chemicals, Inc.

balance-sheet-analysis-chart MITSUI-CHEMICALS-INC

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	379,091	314,229	441,438	551,939	546,466	574,594	589,044	595,750
Change	-	-17.11%	40.48%	25.03%	-0.99%	5.15%	2.51%	1.14%
Announcement Date	5/14/20	5/13/21	5/13/22	5/12/23	5/15/24	-	-	-

¹JPY in Million

Estimates

Cash Flow Forecast: Mitsui Chemicals, Inc.

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	76,294	93,170	207,132	168,002	185,703	167,020	163,820	165,220
Change	-	22.12%	122.32%	-18.89%	10.54%	-10.06%	-1.92%	0.85%
Free Cash Flow (FCF) ¹	38,680	96,768	-112,650	-5,099	37,400	31,833	5,750	58,200
Change	-	150.18%	-216.41%	-95.47%	-833.48%	-14.88%	-81.94%	912.17%
Announcement Date	5/14/20	5/13/21	5/13/22	5/12/23	5/15/24	-	-	-

¹JPY in Million

Estimates

Forecast Financial Ratios: Mitsui Chemicals, Inc.

Fiscal Period: March	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	9.24%	12.65%	14.36%	11.76%	9.68%	11.21%	12.62%	13.45%
EBIT Margin (%)	5.35%	7.03%	9.13%	6.86%	4.24%	5.59%	6.79%	7.55%
EBT Margin (%)	5.11%	6.13%	8.76%	6.24%	4.19%	5.22%	6.46%	7.31%
Net margin (%)	2.83%	4.78%	6.82%	4.41%	2.86%	3.48%	4.36%	4.95%
FCF margin (%)	2.89%	7.99%	-6.99%	-0.27%	2.14%	1.75%	0.31%	3.06%
FCF / Net Income (%)	101.94%	167.21%	-102.42%	-6.15%	74.8%	50.27%	7.07%	61.79%
Profitability
ROA	4.4%	3.75%	8.09%	5.86%	3.42%	3.82%	4.63%	4.98%
ROE	7%	10.18%	16.7%	11.1%	6.1%	7.22%	9.44%	9.92%
Financial Health
Leverage (Debt/EBITDA)	3.06x	2.05x	1.91x	2.5x	3.23x	2.81x	2.5x	2.33x
Debt / Free cash flow	9.8x	3.25x	-3.92x	-108.24x	14.61x	18.05x	102.44x	10.24x
Capital Intensity
CAPEX / Current Assets (%)	5.7%	7.69%	12.84%	8.94%	10.61%	9.17%	8.78%	8.68%
CAPEX / EBITDA (%)	61.66%	60.8%	89.46%	75.99%	109.64%	81.8%	69.54%	64.52%
CAPEX / FCF (%)	197.24%	96.28%	-183.87%	-3,294.8%	496.53%	524.67%	2,849.04%	283.88%
Items per share
Cash flow per share ¹	459.3	692.6	998.4	909.9	764	890.1	1,002	1,032
Change	-	50.77%	44.17%	-8.87%	-16.04%	16.51%	12.62%	2.97%
Dividend per Share ¹	100	100	120	120	140	152	162	173.3
Change	-	0%	20%	0%	16.67%	8.57%	6.58%	7%
Book Value Per Share ¹	2,762	3,103	3,688	4,140	4,538	4,712	5,023	5,384
Change	-	12.33%	18.87%	12.25%	9.62%	3.83%	6.6%	7.19%
EPS ¹	194.9	298	565.4	431.2	263	334.2	431.7	503.4
Change	-	52.87%	89.75%	-23.75%	-39.01%	27.08%	29.16%	16.61%
Nbr of stocks (in thousands)	193,736	195,949	193,238	191,131	190,138	185,156	185,156	185,156
Announcement Date	5/14/20	5/13/21	5/13/22	5/12/23	5/15/24	-	-	-